Identification of a Novel Somatic Mutation Leading to Allele Dropout for EGFR L858R Genotyping in Non-Small Cell Lung Cancer

被引：0
|
作者：
Helio A. Costa
Joel W. Neal
Carlos D. Bustamante
James L. Zehnder
机构：
[1] Stanford University School of Medicine,Department of Genetics
[2] Stanford University School of Medicine,Division of Oncology, Department of Medicine
[3] Stanford University School of Medicine,Department of Biomedical Data Science
[4] Stanford University School of Medicine,Department of Pathology
来源：
Molecular Diagnosis & Therapy | 2017年 / 21卷
关键词：
Epidermal Growth Factor Receptor; Epidermal Growth Factor Receptor Mutation; Epidermal Growth Factor Receptor Gene; L858R Mutation; Epidermal Growth Factor Receptor Mutation Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 436
页数：5
相关论文
共 50 条
  • [1] Identification of a Novel Somatic Mutation Leading to Allele Dropout for EGFR L858R Genotyping in Non-Small Cell Lung Cancer
    Costa, Helio A.
    Neal, Joel W.
    Bustamante, Carlos D.
    Zehnder, James L.
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (04) : 431 - 436
  • [2] The L858R mutation of the EGFR gene might be associated with smoking in non-small cell lung cancer
    Buyru, Nur
    Baykara, Onur
    Tansarikaya, Merve
    Ulutin, Turgut
    [J]. CANCER RESEARCH, 2011, 71
  • [3] The Performance of an L858R Mutation Specific EGFR Antibody in Non-Small Cell Lung Cancer Specimens
    Kyshtoobayeva, A.
    Bloom, K. J.
    [J]. MODERN PATHOLOGY, 2012, 25 : 480A - 481A
  • [4] The Performance of an L858R Mutation Specific EGFR Antibody in Non-Small Cell Lung Cancer Specimens
    Kyshtoobayeva, A.
    Bloom, K. J.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 480A - 481A
  • [5] Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy
    Arora, Rohan
    Krishnan, Venkat
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [6] Potent, novel small molecule inhibitors targeting EGFR L858R/T790M mutation for non-small cell lung cancer
    Sivanandhan, Dhanalakshmi
    Parikh, Payal K.
    Sheshachalam, Avinash
    Chandregowda, V
    Bhakthavatchalam, Rajagopal
    Gupta, Manish
    Giri, Sanjeev
    Krishnakumar, V
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [7] Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation
    Jiang, Zhansheng
    Li, Yong
    Yan, Zhuchen
    Lan, Lan
    Zhang, Xinwei
    Ren, Baozhu
    Wang, Fei
    Zhang, Wencheng
    Pan, Zhanyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Erlotinib Resistance with EGFR L858R/Y891D Double Mutation in a Patient with Non-Small Cell Lung Cancer
    Qin, Jiayue
    Wang, Juan
    Lin, Xiaoyi
    Wang, Jiawei
    Xiong, Zhicheng
    Wang, Ruixiao
    Zhao, Hongmei
    Kong, Xiangquan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : E65 - E68
  • [9] Wighteone exhibits an antitumor effect against EGFR L858R/T790M mutation non-small cell lung cancer
    Sun, Peiyuan
    Qu, Yana
    Wang, Yuna
    Wang, Jing
    Wang, Xuanjun
    Sheng, Jun
    [J]. JOURNAL OF CANCER, 2021, 12 (13): : 3900 - 3908
  • [10] Detecting EGFR exon 19 deletions and L858R in patients with non small cell lung cancer
    Hammoudeh, Z. A.
    Koleva, V.
    Kyuchukov, Y.
    Dakova, P.
    Penev, A.
    Minchev, T.
    Toncheva, D.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 582 - 582
12345